Skip to main content

Table 2 Fasting lipids and apolipoproteins 1

From: Racial differences between African-American and white women in insulin resistance and visceral adiposity are associated with differences in apoCIII containing apoAI and apoB lipoproteins

Variable African-Americans (n = 14) Whites (n = 18) P-Value2
Cholesterol (mg/dL) 185 ± 41 172 ± 35 0.20
TG (mg/dL) 79 ± 45 98 ± 50 0.15
HDL cholestrol (mg/dL) 56 ± 14 49 ± 11 0.10
LDL cholesterol (mg/dL) 113 ± 34 102 ± 29 0.23
ApoAI (mg/dL) 175 ± 32 167 ± 30 0.52
Apo AI of HDL with ApoC-III (mg/dL) 13.2 ± 3.0 12.7 ± 2.6 0.57
Apo AI of HDL without ApoC-III (mg/dL) 162 ± 30 154 ± 28 0.52
ApoCIII (mg/dL) 10.4 ± 3.7 9.6 ± 3.9 0.55
HDL-ApoCIII (mg/dL) 7.0 ± 2.9 5.7 ± 3.1 0.23
Light VLDL-ApoCIII (mg/dL) 1.5 ± 1.4 1.7 ± 1.1 0.60
Dense VLDL-ApoCIII (mg/dL) 0.61 ± 0.55 0.93 ± 0.51 0.10
IDL-ApoCIII (mg/dL) 0.28 ± 0.29 0.32 ± 0.28 0.68
LDL-ApoCIII (mg/dL) 1.0 ± 0.6 1.0 ± 0.5 0.68
  1. 1Data presented as mean ± SD.
  2. 2Comparisons by unpaired t-tests.